The impact of dose delivery time on biological effectiveness in proton irradiation with various biological parameters
Authors:
- 11 July 2020
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 47 (9) , 4644-4655
Abstract
Purpose The purpose of this study is to evaluate the sub‐lethal damage (SLD) repair effect in prolonged proton irradiation using the biophysical model with various cell‐specific parameters of (α /β )x and T 1/2 (repair half time). At present, most of the model‐based studies on protons have focused on acute radiation, neglecting the reduction in biological effectiveness due to SLD repair during the delivery of radiation. Nevertheless, the dose‐rate dependency of biological effectiveness may become more important as advanced treatment techniques, such as hypofractionation and respiratory gating, come into clinical practice, as these techniques sometimes require long treatment times. Also, while previous research using the biophysical model revealed a large repair effect with a high physical dose, the dependence of the repair effect on cell‐specific parameters has not been evaluated systematically. Methods Biological dose (relative biological effectiveness (RBE ) × physical dose) calculation with repair included was carried out using the linear energy transfer (LET)‐dependent linear‐quadratic (LQ) model combined with the theory of dual radiation action (TDRA). First, we extended the dose protraction factor in the LQ model for the arbitrary number of different LET proton irradiations delivered sequentially with arbitrary time lags, referring to the TDRA. Using the LQ model, the decrease in biological dose due to SLD repair was systematically evaluated for spread‐out Bragg peak (SOBP) irradiation in a water phantom with the possible ranges of both (α /β )x and repair parameters ((α /β )x = 1–15 Gy, T 1/2 = 0–90 min). Then, to consider more realistic irradiation conditions, clinical cases of prostate, liver, and lung tumors were examined with the cell‐specific parameters for each tumor obtained from the literature. Biological D 99% and biological dose homogeneity coefficient (HC) were calculated for the clinical target volumes (CTVs), assuming dose‐rate structures with a total irradiation time of 0–60 min. Results The differences in the cell‐specific parameters resulted in considerable variation in the repair effect. The biological dose reduction found at the center of the SOBP with 30 min of continuous irradiation varied from 1.13% to 14.4% with a T 1/2 range of 1–90 min when (α /β )x is fixed as 10 Gy. It varied from 2.3% to 6.8% with an (α /β )x range of 1–15 Gy for a fixed value of T 1/2 = 30 min. The decrease in biological D 99% per 10 min was 2.6, 1.2, and 3.0% for the prostate, liver, and lung tumor cases, respectively. The value of the biological D 99% reduction was neither in the order of (α /β )x nor prescribed dose, but both comparably contributed to the repair effect. The variation of HC was within the range of 0.5% for all cases; therefore, the dose distribution was not distorted. Conclusion The reduction in biological dose caused by the SLD repair largely depends on the cell‐specific parameters in addition to the physical dose. The parameters should be considered carefully in the evaluation of the repair effect in prolonged proton irradiation.Keywords
Funding Information
- Japan Society for the Promotion of Science (18K07621, 18H02758)
This publication has 32 references indexed in Scilit:
- Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liverPhysics in Medicine & Biology, 2013
- Microdosimetric calculation of relative biological effectiveness for design of therapeutic proton beamsJournal of Radiation Research, 2012
- Low LET protons focused to submicrometer shows enhanced radiobiological effectivenessPhysics in Medicine & Biology, 2012
- A Mechanism-Based Approach to Predict the Relative Biological Effectiveness of Protons and Carbon Ions in Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Motion in radiotherapy: particle therapyPhysics in Medicine & Biology, 2011
- Efficiency of respiratory-gated delivery of synchrotron-based pulsed proton irradiationPhysics in Medicine & Biology, 2008
- Hypofractionated Proton Beam Radiotherapy for Stage I Lung CancerChest, 2004
- How low is the α/β ratio for prostate cancer?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Is α/β for prostate tumors really low?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Conditions for the equivalence of continuous to pulsed low dose rate brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991